ALA

DRUG7 trials

Sponsors

Tata Memorial Hospital, USDA Grand Forks Human Nutrition Research Center, DUSA Pharmaceuticals, Inc., University of Eastern Finland, Shanghai Dermatology Hospital

Conditions

Actinic KeratosesActinic KeratosisBasal Cell CarcinomaFatty AcidsGeneticsMalignant GliomasObesity

Phase 2

Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face

CompletedNCT02632110

DUSA Pharmaceuticals, Inc.Actinic Keratosis

Start: 2016-03-31End: 2016-09-12Updated: 2018-01-18

Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy

RecruitingNCT05020912

Case Comprehensive Cancer CenterBasal Cell Carcinoma

Start: 2021-12-13End: 2027-12-31Target: 28Updated: 2025-11-26

Phase 3

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

WithdrawnNCT03024060

DUSA Pharmaceuticals, Inc.Actinic Keratosis

Start: 2017-03-31End: 2018-01-31Updated: 2017-11-07

Phase 4

Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention

Shanghai Dermatology HospitalActinic Keratoses

Start: 2018-08-30End: 2025-06-01Target: 300Updated: 2019-03-19

Unknown Phase

Fluorescence and Glioma Heterogeneity

CompletedNCT02155452

Tata Memorial HospitalMalignant Gliomas

Start: 2014-05-31End: 2019-07-31Updated: 2022-05-06

Acute Effects of Fats on Satiety and Energy Needs

CompletedNCT02496936

USDA Grand Forks Human Nutrition Research CenterObesity

Start: 2015-12-31End: 2019-10-30Updated: 2022-08-04

Fatty Acid Desaturase Gene Locus Interactions With Diet (FADSDIET2)

CompletedNCT03572205

University of Eastern FinlandFatty Acids, Genetics

Start: 2018-08-13End: 2018-12-19Updated: 2019-04-18